Clinical Trial Update: Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pioglitazone and SGLT2 inhibitors versus DPP-4 inhibitors in patients with diabetes mellitus and stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Stroke

Drugs mentioned

• DPP-4 inhibitors
• PIOGLITAZONE (Pioglitazone)
• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Diabetes Mellitus, Stroke | Phase 2 | Status: UNKNOWN